A nuclear cardiac stress test administered shortly after a coronary angioplasty with stent implantation may give important clues to whether the procedure was successful or whether the patient will require more procedures.
For the first time, researchers have shown that high triglycerides – a type of blood fat – are a strong independent predictor of a person’s risk for stroke.
Researchers continue to develop treatments for this condition, in which the heart cannot adequately pump blood around the body, causing fluid to seep into the lungs and hinder breathing. Two of these treatments - a drug injection and a new type of pacemaker -recently were approved by the FDA.
Mounting scientific evidence has suggested that a significant link exists between heart and gum disease.
Around a third of all heart attacks and strokes can be avoided in people at risk of vascular disease by using statin drugs to lower blood cholesterol levels – irrespective of the person’s age or sex, and even if their cholesterol levels do not seem high.
Short-legged men have an increased risk of heart disease and a condition that leads to diabetes, insulin resistance syndrome, shows research in the Journal of Epidemiology and Community Health.
Nutrition researchers at Kansas State University have published the first evidence that the absorption of cholesterol is reduced by another compound in the egg, a lecithin.
While GPs’ understanding of the definition of insulin resistance is excellent (85% know it is the inability of the body to respond to its own insulin), the number of patients that it affects is being greatly underestimated.
Colesevelam hydrochloride appears to be an effective lipid-lowering agent that significantly reduces low-density lipoprotein (LDL) cholesterol levels, according to a study published in the October issue of Mayo Clinic Proceedings.
A study by Liu et al. strengthens the evidence that glycemic load, a measure of carbohydrate intake, can predict cardiovascular disease (CVD) risk, especially in those who are insulin resistant.
Estrogen Doesn’t Prevent Second Strokes: Protective Effects of Hormone Replacement Therapy Challenged
Estrogen hormone replacement therapy does not reduce the risk of stroke or death in postmenopausal women who have already had a stroke or a transient ischemic attack, according to a report.
The number of Americans who are hospitalized for stroke continues to increase, but the death rate is declining, according to a recent report.
Challenging one of medicine's long-standing beliefs, a team of scientists funded by the National Heart, Lung, and Blood Institute (NHLBI) and the National Institute on Aging (NIA) has found the strongest evidence to date that human heart muscle cells regenerate after a heart attack.
An anti-clotting drug is as effective as aspirin at preventing a second stroke, but without the bleeding complication sometimes associated with aspirin use, according to two new studies.
Research findings released today at the American Diabetes Association’s (ADA) annual meeting shed new light on the connection between diabetes and cardiovascular disease.
In one of the largest analyses of its kind, researchers found that most middle-aged and older individuals with high blood pressure have a form of the disease in which their systolic pressure – the top number in a blood pressure reading – is too high, according to a study in the March issue of Hypertension: Journal of the American Heart Association.